About OriGene
OriGene is a company based in Rockville (United States) founded in 1996. OriGene has raised $69.55 million across 11 funding rounds from investors including Kleiner Perkins, Uni-President and HHS. OriGene has completed 3 acquisitions, including Blue Heron Bio, Marligen Biosciences and biocheckinc.com. OriGene operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Origene Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$69.55 M (USD)
in 11 rounds
-
Latest Funding Round
$17.05 M (USD), Series D
Jun 09, 2015
-
Investors
Kleiner Perkins
& 10 more
-
Employee Count
Not available
-
Investments & Acquisitions
Blue Heron Bio
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of OriGene
Unlock access to complete
Funding Insights of OriGene
OriGene has successfully raised a total of $69.55M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $17.05 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OriGene
OriGene has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Uni-President and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cathay Capital is engaged in global investment and transformation.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm
|
Locked | Locked | Locked |
Investor details for OriGene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OriGene
OriGene has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Blue Heron Bio, Marligen Biosciences and biocheckinc.com.
Investment portfolio details for OriGene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information available
|
Locked | Locked | 2001 | Locked | |
|
Gene synthesis and sequencing services are provided using proprietary technology.
|
Locked | Locked | 1999 | Locked | |
|
In-vitro diagnostic kits and research reagents are developed and marketed.
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for OriGene
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - OriGene
Detailed financials for OriGene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Origene Comparisons
Peer comparison for OriGene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OriGene
OriGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of OriGene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Origene
Complete news archive for OriGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OriGene
OriGene was founded in 1996 and raised its 1st funding round 8 years after it was founded.
OriGene is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
OriGene is a funded company, having raised a total of $69.55M across 11 funding rounds to date.
OriGene Technologies is focused on developing proteins, antibodies, and other molecular tools to support the academic, pharmaceutical, and biotech companies in their research of gene functions and drug discovery. Its product lines include the large cDNA and shRNA clone collections, about 5k purified human proteins, monoclonal antibodies (TrueMAB), 140k validated human tissues, and protein microarray products. It also provides a range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from the Companys tissue collection.
OriGene's top competitors include Abcam, Sino Biological and Meridian Bioscience.
OriGene has made 3 acquisitions, including Blue Heron Bio, Marligen Biosciences, and biocheckinc.com.
OriGene has 11 investors. Key investors include Kleiner Perkins, Uni-President, HHS, Qiming Venture Partners, and NHGRI.